A note on continual reassessment method

DOI10.1016/J.SPL.2016.02.019zbMath1419.62457OpenAlexW2294382611MaRDI QIDQ274178

F. Blanchet-Sadri, M. Dambrine

Publication date: 22 April 2016

Published in: Statistics \& Probability Letters (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.spl.2016.02.019

zbMATH Keywords

optimal designdose-finding studiesmaximum tolerated dosephase I clinical trial

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Generalized linear models (logistic models) (62J12)

Cites Work

• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• The treatment versus experimentation dilemma in dose finding studies
• On the de la Garza phenomenon
• Bayesian experimental design: A review
• Design and Analysis of Phase I Clinical Trials
• Optimum Allocation in Linear Regression Theory

This page was built for publication: A note on continual reassessment method